{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:49Z","timestamp":1786119409553,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/wnf.0b013e3181c295c1","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T01:51:56Z","timestamp":1267062716000},"page":"32-34","source":"Crossref","is-referenced-by-count":37,"title":["Topiramate in Treatment of Tourette Syndrome"],"prefix":"10.1097","volume":"33","author":[{"given":"Sheng-Han","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohi","family":"Jimenez-Shahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210203","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMra010032","article-title":"Tourette's syndrome.","volume":"345","author":"Jankovic","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-8-20210203","first-page":"651","article-title":"Tourette's syndrome.","volume":"77","author":"Kenney","year":"2008","journal-title":"Am Fam Physician"},{"issue":"Pt 3","key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/brain\/123.3.425","article-title":"Tourette syndrome, associated conditions and the complexities of treatment.","volume":"123","author":"Robertson","year":"2000","journal-title":"Brain"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1176\/appi.ajp.158.6.968","article-title":"Control of Tourette's syndrome with topiramate.","volume":"158","author":"Abuzzahab","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneur.1993.00540100012008","article-title":"Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group.","volume":"50","year":"1993","journal-title":"Arch Neurol"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","article-title":"Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.","volume":"154","author":"Sallee","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R7-8-20210203","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1212\/WNL.48.2.358","article-title":"Long-term effects of tetrabenazine in hyperkinetic movement disorders.","volume":"48","author":"Jankovic","year":"1997","journal-title":"Neurology"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneur.57.8.1190","article-title":"Botulinum toxin in the treatment of tics.","volume":"57","author":"Kwak","year":"2000","journal-title":"Arch Neurol"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1212\/01.wnl.0000250354.81556.90","article-title":"GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities.","volume":"68","author":"Shahed","year":"2007","journal-title":"Neurology"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tins.2006.01.001","article-title":"Recent advances in Tourette syndrome research.","volume":"29","author":"Albin","year":"2006","journal-title":"Trends Neurosci"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1469-7610.2006.01620.x","article-title":"Annotation: Tourette syndrome: a relentless drumbeat-driven by misguided brain oscillations.","volume":"47","author":"Leckman","year":"2006","journal-title":"J Child Psychol Psychiatry"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1073\/pnas.0502624102","article-title":"Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome.","volume":"102","author":"Kalanithi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-859X-4-5","article-title":"Review of the use of Topiramate for treatment of psychiatric disorders.","volume":"4","author":"Arnone","year":"2005","journal-title":"Ann Gen Psychiatry"},{"key":"R14-8-20210203","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/0883073807303997","article-title":"Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents.","volume":"22","author":"Glauser","year":"2007","journal-title":"J Child Neurol"},{"key":"R15-8-20210203","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0883073807304201","article-title":"Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial.","volume":"22","author":"Lakshmi","year":"2007","journal-title":"J Child Neurol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201001000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:30Z","timestamp":1786039890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201001000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181c295c1","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}